Contrary to our expectations, inactivating one Ins2 allele did not consistently cause a reduction of circulating insulin in Ins1-null male mice, which precluded us from properly testing the hypothesis that reduced Ins2 dosage and lower insulin levels would lead to protection from obesity in males. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.